Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Rufinamide recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Rufinamide (4 total). Check the affected lots below.

Most common reason: cGMP deviation (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Rufinamide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Rufinamide recalls on record

none so far in 2026; 4 on record, newest first
Class II · Moderate risk

Rufinamide Tablets

cGMP deviations: Batch was released prior to approval.

Terminated cGMP deviation Aurobindo Pharma USA Inc. NDC 59651-617-08 D-1088-2023
Class II · Moderate risk

Rufinamide Tablets

cGMP deviations: Batch was released prior to approval.

Terminated cGMP deviation Aurobindo Pharma USA Inc. NDC 59651-616-08 D-1087-2023
Class II · Moderate risk

Banzel (rufinamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 62856-582-52 D-0472-2021